Treatment of Obesity in Patients With Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
IN BRIEF More than 90% of patients with diabetes have overweight or obesity. Whereas weight gain and obesity worsen insulin resistance, weight loss slows the progression of diabetes complications. Given the elevated risk for diabetes complications in patients with obesity, clinicians must understand how to treat obesity in their patients with diabetes, including providing counseling and behavioral management, referral to weight loss programs, and medication management. This article summarizes guidelines for diagnosing and managing obesity in people with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“Another community referral option is the Centers for Disease Control and Prevention (CDC) National Diabetes Prevention Program (DPP), which is based on the Diabetes Prevention Program RCT, in which an intensive behavioral program delayed the development of type 2 diabetes and showed a 58% reduced progression to diabet…”
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867
Dansinger, M. L., Gleason, J. A., Griffith, J. L., Selker, H. P., & Schaefer, E. J. (2005) · JAMA · doi:10.1001/jama.293.1.43 · Cited by 1,726 · cited 1×
“It is important to understand that reducing caloric intake is more effective at achieving initial weight loss than only increasing exercise (48,49).”
BackgroundPharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347 · cited 1×
“When possible, clinicians should attempt to reduce or find alternatives to common medications that can increase appetite and promote weight gain, including sedating antihistamines, steroids, some selective serotonin reuptake inhibitors, beta-blockers, and most antipsychotic agents (62).”
BackgroundEvaluating primary care behavioral counseling interventions An evidence-based approach
Whitlock, E. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00415-4 · Cited by 1,057
(2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30162-0 · Cited by 738
Klonoff, D. C., Buse, J. B., Nielsen, L. L., Guan, X., Bowlus, C. L., Holcombe, J. H., Wintle, M. E., & Maggs, D. G. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x253870 · Cited by 699
Barriers to Providing Nutrition Counseling by Physicians: A Survey of Primary Care Practitioners
Kushner, R. F. (1995) · Preventive Medicine · doi:10.1006/pmed.1995.1087 · Cited by 604 · cited 1×
“Previous studies have shown that a lack of time and training limits clinicians’ desire to engage patients in weight management discussions (7,8).”
BackgroundThe Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1299 · Cited by 494
Consistent Self‐monitoring of Weight: A Key Component of Successful Weight Loss Maintenance
Butryn, M. L., Phelan, S., Hill, J. O., & Wing, R. R. (2007) · Obesity · doi:10.1038/oby.2007.368 · Cited by 483 · cited 1×
“Daily self-weighing has been shown to improve individuals’ ability to refrain from excess caloric intake (51) and thus promotes weight loss (52).”
BackgroundGarber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2017) · Endocrine Practice · doi:10.4158/ep161682.cs · Cited by 435 · cited 3×
“The AACE/ACE guidelines recommend monitoring patients who are on insulin or sulfonylureas for hypoglycemia after starting any weight loss medication (2,53).”
MethodJolly, K., Lewis, A., Beach, J., Denley, J., Adab, P., Deeks, J. J., Daley, A., & Aveyard, P. (2011) · BMJ · doi:10.1136/bmj.d6500 · Cited by 359 · cited 1×
“The 2016 ADA guidelines and the 2013 AHA/ ACC/TOS guidelines recommend that clinicians refer patients with obesity and type 2 diabetes to high-intensity programs (3,23,31).”
BackgroundTemporal patterns in overweight and obesity in type 1 diabetes
Conway, B., Miller, R. G., Costacou, T., Fried, L., Kelsey, S., Evans, R. W., & Orchard, T. J. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02956.x · Cited by 326 · cited 1×
“Diabetes Obesity is increasingly common in patients with type 1 diabetes; in 1988, 25% of 40- to 49-year-olds with type 1 diabetes had overweight or obesity compared to 68% in 2007 (71).”
BackgroundEfficacy of Commercial Weight-Loss Programs: An Updated Systematic Review
Gudzune, K. A., Doshi, R. S., Mehta, A. K., Chaudhry, Z. W., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., & Clark, J. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2238 · Cited by 325
Self-citationAronne, L., Fujioka, K., Aroda, V., Chen, K., Halseth, A., Kesty, N. C., Burns, C., Lush, C. W., & Weyer, C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2003 · Cited by 178 · cited 1×
“7-kg weight loss, pramlintide can also lower daily insulin requirements in patients with diabetes on insulin therapy (57).”
BackgroundThe Look AHEAD Trial: a review and discussion of its outcomes
Pi-Sunyer, X. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0099-x · Cited by 176 · cited 1×
“Although the intervention group did not achieve a significant reduction in cardiovascular events compared to the control group, numerous other health improvements occurred, including reduced sleep apnea, lower A1C, reduced need for diabetes medications, improved mobility and quality of life, fewer hospitalizations, an…”
BackgroundEspeland, M. A., Glick, H. A., Bertoni, A., Brancati, F. L., Bray, G. A., Clark, J. M., Curtis, J. M., Egan, C., Evans, M., Foreyt, J. P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0093 · Cited by 174
Jay, M., Gillespie, C., Schlair, S., Sherman, S., & Kalet, A. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-159 · Cited by 158
Rock, C. L., Flatt, S. W., Pakiz, B., Taylor, K. S., Leone, A. F., Brelje, K., Heath, D. D., Quintana, E. L., & Sherwood, N. E. (2014) · Diabetes Care · doi:10.2337/dc13-2900 · Cited by 139
Weight loss counseling revisited.
Serdula, M. K., Khan, L. K., & Dietz, W. H. (2003) · JAMA · doi:10.1001/jama.289.14.1747 · Cited by 115
Gudzune, K. A., Bennett, W. L., Cooper, L. A., & Bleich, S. N. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.02.001 · Cited by 114
Self-citationRapp, S. R., Luchsinger, J. A., Baker, L. D., Blackburn, G. L., Hazuda, H. P., Demos‐McDermott, K. E., Jeffery, R. W., Keller, J. N., McCaffery, J. M., Pajewski, N. M., et al. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14692 · Cited by 62
Fontbonne, A., Diouf, I., Baccara-Dinet, M., Eschwege, E., & Charles, M.-A. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.03.005 · Cited by 53
Maintenance of Weight Loss After Initiation of Nutrition Training: A Randomized Trial
Voils, C. I., Olsen, M. K., Gierisch, J. M., McVay, M. A., Grubber, J. M., Gaillard, L., Bolton, J., Maciejewski, M. L., Strawbridge, E., & Yancy, W. S. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2160 · Cited by 50 · cited 1×
“Self-monitoring is another important tool in weight loss and weight maintenance efforts (50).”
MethodLiraglutide 3.0 mg for weight management: weight-loss dependent and independent effects
Bays, H., Pi-Sunyer, X., Hemmingsson, J. U., Claudius, B., Jensen, C. B., & Van Gaal, L. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1251892 · Cited by 48
Chaudhry, Z. W., Doshi, R. S., Mehta, A. K., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., Kalyani, R. R., Clark, J. M., & Gudzune, K. A. (2016) · Obesity Reviews · doi:10.1111/obr.12423 · Cited by 16
Self-citation
Research works printed but not linked: 34
- Macumber, 2017, Maternal obesity is associated with congenital anomalies of the kidney and urinary tract in offspring, Pediatr Nephrol, 32, 635, 10.1007/s00467-016-3543-x · DOI
- Mitchell, 2016, Understanding the effect of obesity on fertility among reproductive-age women, Nurs Womens Health, 20, 368, 10.1016/j.nwh.2016.07.001 · DOI
- Simeone, 2016, Proportion of selected congenital heart defects attributable to recognized risk factors, Ann Epidemiol, 26, 838, 10.1016/j.annepidem.2016.10.003 · DOI
- Bleich, 2012, National survey of US primary care physicians' perspectives about causes of obesity and solutions to improve care, BMJ Open, 2, 10.1136/bmjopen-2012-001871 · DOI
- Bennett, 2014, Insights from the POWER practice-based weight loss trial: a focus group study on the PCP's role in weight management, J Gen Intern Med, 29, 50, 10.1007/s11606-013-2562-6 · DOI
- Bennett, 2015, Satisfaction with primary care provider involvement is associated with greater weight loss: results from the practice-based POWER trial, Patient Educ Couns, 98, 1099, 10.1016/j.pec.2015.05.006 · DOI · Paper page
- Moyer, 2012, Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 157, 373, 10.7326/0003-4819-157-5-201209040-00475 · DOI · Paper page
- Leblanc, 2011, Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force, Ann Intern Med, 155, 434, 10.7326/0003-4819-155-7-201110040-00006 · DOI · Paper page
- Look AHEAD Research Group, 2017, Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study, Diabetologia, 60, 980, 10.1007/s00125-017-4253-z · DOI · Paper page
- Huizinga, 2009, Physician respect for patients with obesity, J Gen Intern Med, 24, 1236, 10.1007/s11606-009-1104-8 · DOI · Paper page
- Puhl, 2007, Internalization of weight bias: implications for binge eating and emotional well-being, Obesity (Silver Spring), 15, 19, 10.1038/oby.2007.521 · DOI · Paper page
- Alexander, 2011, Do the five A's work when physicians counsel about weight loss?, Fam Med, 43, 179
- Gudzune, 2016, Dietary and behavioral approaches in the management of obesity, Gastroenterol Clin North Am, 45, 653, 10.1016/j.gtc.2016.07.004 · DOI
- American Diabetes Association, 2016, Standards of medical care in diabetes—2016: abridged for primary care providers, Clin Diabetes, 34, 3, 10.2337/diaclin.34.1.3 · DOI · Paper page
- Gibbs, 2014, Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study, Eur J Prev Cardiol, 21, 608, 10.1177/2047487312462823 · DOI · Paper page
- Wing, 2013, Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study, Diabetes Care, 36, 2937, 10.2337/dc13-0315 · DOI · Paper page
- Bloom, 2016, Guideline-concordant weight-loss programs in an urban area are uncommon and difficult to identify through the Internet, Obesity (Silver Spring), 24, 583, 10.1002/oby.21403 · DOI · Paper page
- Foster, 2013, A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program, Nutr Diabetes, 3, e63, 10.1038/nutd.2013.3 · DOI · Paper page
- Pinto, 2013, Combining behavioral weight loss treatment and a commercial program: a randomized clinical trial, Obesity (Silver Spring), 21, 673, 10.1002/oby.20044 · DOI · Paper page
- Foster, 2009, The effects of a commercially available weight loss program among obese patients with type 2 diabetes: a randomized study, Postgrad Med, 121, 113, 10.3810/pgm.2009.09.2046 · DOI · Paper page
- Rock, 2007, Randomized trial of a multifaceted commercial weight loss program, Obesity (Silver Spring), 15, 939, 10.1038/oby.2007.614 · DOI · Paper page
- Jolly, 2010, A randomised controlled trial to compare a range of commercial or primary care led weight reduction programmes with a minimal intervention control for weight loss in obesity: the Lighten Up trial, BMC Public Health, 10, 439, 10.1186/1471-2458-10-439 · DOI · Paper page
- Johnston, 2014, Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis, JAMA, 312, 923, 10.1001/jama.2014.10397 · DOI · Paper page
- Wing, 1998, Lifestyle intervention in overweight individuals with a family history of diabetes, Diabetes Care, 21, 350, 10.2337/diacare.21.3.350 · DOI · Paper page
- Helander, 2014, Are breaks in daily self-weighing associated with weight gain?, PLoS One, 9, 10.1371/journal.pone.0113164 · DOI · Paper page
- Seifarth, 2013, Effectiveness of metformin on weight loss in non-diabetic individuals with obesity, Exp Clin Endocrinol Diabetes, 121, 27
- Pratley, 2009, Alogliptin Study Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy, Diabetes Obes Metab, 11, 167, 10.1111/j.1463-1326.2008.01016.x · DOI · Paper page
- Raz, 2008, Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes, Curr Med Res Opin, 24, 537, 10.1185/030079908X260925 · DOI · Paper page
- Rosenstock, 2014, Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes, Diabetes Care, 37, 1815, 10.2337/dc13-3055 · DOI · Paper page
- Goldstein, 1992, Beneficial health effects of modest weight loss, Int J Obes Relat Metab Disord, 16, 397
- Jacob, 2009, Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss, Diabetes Obes Metab, 11, 361, 10.1111/j.1463-1326.2008.00970.x · DOI · Paper page
- Mahgerefteh, 2013, New drug therapies for the treatment of overweight and obese patients, Am Health Drug Benefits, 6, 423
- Garvey, 2012, Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study, Am J Clin Nutr, 95, 297, 10.3945/ajcn.111.024927 · DOI · Paper page
- Makowski, 2011, Naltrexone/bupropion: an investigational combination for weight loss and maintenance, Obes Facts, 4, 489, 10.1159/000335352 · DOI
Cited by
Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., Rosenstock, J., Shimomura, I., Viljoen, A., Wadden, T. A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00213-0 · Cited by 1,419
Badve, S. V., Bilal, A., Lee, M. M. Y., Sattar, N., Gerstein, H. C., Ruff, C. T., McMurray, J. J. V., Rossing, P., Bakris, G., Mahaffey, K. W., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00271-7 · Cited by 359
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
Davies, M. J., Bajaj, H. S., Broholm, C., Eliasen, A., Garvey, W. T., le Roux, C. W., Lingvay, I., Lyndgaard, C. B., Rosenstock, J., & Pedersen, S. D. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2502082 · Cited by 143
Perspectives in weight control in diabetes - survodutide
Klein, T., Augustin, R., & Hennige, A. M. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110779 · Cited by 25
Heymsfield, S. B., Raji, A., Gallo, S., Liu, J., Pong, A., Hannachi, H., & Terra, S. G. (2020) · Obesity · doi:10.1002/oby.22748 · Cited by 21
Metadata
- Authors
- Bramante, C. T., Lee, C. J., & Gudzune, K. A.
- Venue
- Diabetes Spectrum
- Publisher
- American Diabetes Association
- Published
- 2017-11-01
- Volume
- 30
- Issue
- 4
- Pages
- 237-243
- ISSN
- 1040-9165 (ISSN-L)
- 1944-7353
- OpenAlex
- W2770569791
- Cited by
- 92
- References
- 32
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.